z-100
Biologicalexperimental
Z100 may refer to: — Wikipedia
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started May 24, 2001 (NCT00016692)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaZ100 ↗
Also known as
- ancer 20
- specific substance maruyama
- z-100
- z-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03476018 | Phase 3 | Apr 2, 2018 | Zeria Pharmaceutical |
| NCT02247232 | Phase 3 | Dec 1, 2014 | Saitama Medical University, Zeria Pharmaceutical |
| NCT00016692 | Phase 1 | May 24, 2001 | Zeria Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zeria Pharmaceutical | For profit | 3 | 3 | 2 | 2001 |
| Saitama Medical University | Academic/Hospital | 1 | 0 | 1 | 2014 |
2 organizations
Page 1 / 1